×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
ENVIRONMENTAL CONSIDERATIONS IN PRODUCTION OF MEDICINAL PRODUCTS
Session Chair(s)
Brendan Barnes
Director, Data Protection & IP
EFPIA, Belgium
Pharmaceuticals in the Environment: Risk assessment and global relevance
Learning Objective : Participants will be informed about the current negotiations on pharmaceuticals in the environment under the Strategic Approach to International Chemicals Management and the results of research on the global relevance of the entry of pharmaceuticals into the environment.
Speaker(s)
Pharmaceuticals in the Environment: Risk assessment and global relevance
Anette Küster, PhD
Federal Environment Agency, Germany
Environmental Risk Assessor
Global Sustainable Production of Pharmaceuticals
Charlotte Unger
Medical Products Agency (MPA), Sweden
Director for Sustainable
EFPIA Perspective
Brendan Barnes
EFPIA, Belgium
Director, Data Protection & IP
Have an account?